Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1317-1323

  Akahoshi, Hiroshi ^a   Taura, Naota ^a   Ichikawa, Tatsuki ^a   Miyaaki, Hisamitsu ^a   Akiyama, Motohisa ^a   Miuma, Satoshi ^a   Ozawa, Eisuke ^a   Takeshita, Shigeyuki ^a   Muraoka, Toru ^a   Matsuzaki, Toshihisa ^a   Ohtani, Masashi ^a   Isomoto, Hajime ^a   Matsumoto, Takehiro ^a   Takeshima, Fuminao ^a   Nakao, Kazuhiko ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Hepatocellular carcinoma; Viral hepatitis

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

AGED; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENDER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; VIRUS;

AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; EARLY DETECTION OF CANCER; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 77950832171     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000766     Document Type: Article

References (39)

1. El-Serag HB and Mason AC: Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160: 3227-3230, 2000.
2. El-Serag HB: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 5: 87-107, 2001.
3. El-Serag HB, Hampel H, Yeh C and Rabeneck L: Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36: 1439-1445, 2002.
4. El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36: S74-S83, 2002.
5. El-Serag HB: Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35: S72-S78, 2002.
6. Hassan MM, Frome A, Patt YZ and El-Serag HB: Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 35: 266-269, 2002.
7. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
8. Kiyosawa K and Tanaka E: Characteristics of hepatocellular carcinoma in Japan. Oncology 62: 5-7, 2002.
9. McGlynn KA, Tsao L, Hsing AW, Devesa SS and Fraumeni JF Jr: International trends and patterns of primary liver cancer. Int J Cancer 94: 290-296, 2001.
10. Bosch FX, Ribes J, Diaz M and Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16, 2004.
11. Hamasaki K, Nakata K, Tsutsumi T, et al: Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan. J Med Virol 40: 146-149, 1993.
12. Kato Y, Nakata K, Omagari K, et al: Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 74: 2234-2238, 1994.
13. Shiratori Y, Shiina S, Imamura M, et al: Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 22: 1027-1033, 1995.
14. Shiratori Y, Shiina S, Zhang PY, et al: Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 80: 2060-2067, 1997.
15. Taura N, Yatsuhashi H, Nakao K, Ichikawa T and Ishibashi H: Long-term trends of the incidence of hepatocellular carcinoma in the Nagasaki prefecture, Japan. Oncol Rep 21: 223-227, 2009.
16. Hatanaka K, Kudo M, Fukunaga T, et al: Clinical characteristics of NonBNonC-HCC: Comparison with HBV and HCV related HCC. Intervirology 50: 24-31, 2007.
17. Omata M, Tateishi R, Yoshida H and Shiina S: Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 127: S159-S166, 2004.
18. Calvet X, Bruix J, Gines P, et al: Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. Hepatology 12: 753-760, 1990.
19. Schafer DF and Sorrell MF: Hepatocellular carcinoma. Lancet 353: 1253-1257, 1999.
20. Akriviadis EA, Llovet JM, Efremidis SC, et al: Hepatocellular carcinoma. Br J Surg 85: 1319-1331, 1998.
21. Ngan H, Lai CL, Fan ST, Lai EC, Yuen WK and Tso WK: Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: four-year follow-up. J Vasc Interv Radiol 7: 419-425, 1996.
22. Oka H, Kurioka N, Kim K, et al: Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 12: 680-687, 1990.
23. Lai CL, Lau JY, Wu PC, et al: Subclinical hepatocellular carcinoma in Hong Kong Chinese. Oncology 49: 347-353, 1992.
24. Colombo M, de Franchis R, Del Ninno E, et al: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325: 675-680, 1991.
25. Pateron D, Ganne N, Trinchet JC, et al: Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 20: 65-71, 1994.
26. Taura N, Hamasaki K, Nakao K, et al: Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospitalbased study. Oncol Rep 14: 999-1003, 2005.
27. Wada I, Hara T, Kajihara S, et al: Population-based study of hepatitis C virus infection and hepatocellular carcinoma in western Japan. Hepatol Res 23: 18-24, 2002.
28. Livraghi T, Bolondi L, Buscarini L, et al: No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol 22: 522-526, 1995.
29. Dohmen K, Shirahama M, Onohara S, et al: Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: an analysis of 547 patients. Hepatol Res 18: 110-121, 2000.
30. Bolondi L, Sofia S, Siringo S, et al: Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48: 251-259, 2001.
31. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG and Lai CL: Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 31: 330-335, 2000.
32. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM and Lok AS: NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36: 1349-1354, 2002.
33. Watabe H, Shiratori Y, Tateishi R, et al: Clinical features of patients with HCC who are negative for both HBV and HCV markers. Hepatogastroenterology 50: 2157-2160, 2003.
34. Kiyosawa K, Umemura T, Ichijo T, et al: Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127: S17-S26, 2004.
35. Umemura T and Kiyosawa K: Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res 37 (Suppl 2): 95-100, 2007.
36. Yoshizawa H: Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 62: 8-17, 2002.
37. Taura N, Hamasaki K, Nakao K, et al: Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan. Oncol Rep 16: 837-843, 2006.
38. Bugianesi E, Leone N, Vanni E, et al: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123: 134-140, 2002.
39. Okuda H, Nakanishi T, Takatsu K, et al: Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol 16: 1290-1296, 2001.